Clark Eliana 4
4 · Intellia Therapeutics, Inc. · Filed Mar 3, 2026
Insider Transaction Report
Form 4
Clark Eliana
EVP, Chief Technical Officer
Transactions
- Award
Common Stock
[F1]2026-03-01+7,353→ 94,471 total - Sale
Common Stock
[F2]2026-03-02$13.78/sh−607$8,364→ 93,864 total - Award
Stock Option (right to buy)
[F3]2026-03-01+10,505→ 10,505 totalExercise: $13.78Exp: 2036-02-29→ Common Stock (10,505 underlying)
Footnotes (3)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- [F2]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on March 1, 2026, and does not represent a volitional trade by the Reporting Person.
- [F3]This option was granted on March 1, 2026 with respect to shares of Common Stock, with 33% vesting on January 1, 2027 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.
Signature
James Basta, attorney-in-fact|2026-03-03